Baseline gene expression patterns of CDK4/6 inhibitor-naïve or -refractory HR+, HER2-negative advanced breast cancer in the Phase Ib study of ribociclib plus everolimus plus exemestane (Abstract poster 10756)
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

全文

其它資訊
著者Aditya Bardia, Shanu Modi, Javier Cortes, Mario Campone, Luc Dirix, Brigette Ma, J Thaddeus Beck, Jorge Chaves, Amy Weise, Jacqueline Vuky, Gilberto Lopes, Miguel Gil-Gil, Xiaochun Liu, Wei He, Faye Su, Michelle Miller, Mariana Chavez-MacGregor
會議名稱AACR Annual Meeting 2018
會議開始日14.04.2018
會議完結日18.04.2018
會議地點Chicago
會議國家/地區美國
出版年份2018
月份4
日期14
語言英式英語
關鍵詞-CDK4/6, breast cancer

上次更新時間 2018-06-11 於 12:36